Soleus Capital Management’s Pulmonx LUNG Stock Holding History

Soleus Capital Management’s Portfolio LUNG Stock Details LUNG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.62M	Hold	2,788,323	–	–	0.12%	79
2026 Q1	$3.6M	Buy	2,788,323 +750,000	+37%	+$1.24M	0.15%	72
2025 Q4	$4.5M	Buy	+2,038,323	New	+$3.83M	0.17%	70
2023 Q3	–	Sell	-41,000	Closed	-$538K	–	106
2023 Q2	$538K	Sell	41,000 -30,000	-42%	-$367K	0.06%	94
2023 Q1	$794K	Hold	71,000	–	–	0.08%	73
2022 Q4	$599K	Buy	+71,000	New	+$675K	0.09%	68
2021 Q4	–	Sell	-87,612	Closed	-$3.15M	–	82
2021 Q3	$3.15M	Buy	87,612 +2,362	+3%	+$92.9K	0.49%	50
2021 Q2	$3.76M	Buy	+85,250	New	+$3.71M	0.58%	36

Other funds holding LUNG

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ECM

ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return

Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Soleus Capital Management's LUNG Position: Q2 2026 in Review

Soleus Capital Management held its Pulmonx (LUNG) position steady in Q2 2026 at 2,788,323 shares worth $3.62M. The position accounts for 0.12% of the portfolio, ranked #79.

Soleus Capital Management first reported a position in LUNG in Q2 2021 and has held it in 8 quarters since. The position peaked at $4.5M in Q4 2025. 108 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.

Soleus Capital Management held 2,788,323 shares of Pulmonx worth $3.62M as of Q2 2026.
Soleus Capital Management left its Pulmonx share count unchanged in Q2 2026.
Pulmonx made up 0.12% of Soleus Capital Management's portfolio in Q2 2026, its #79 holding.
Soleus Capital Management first reported a position in Pulmonx in Q2 2021 and has held it in 8 quarters since.
Soleus Capital Management's Pulmonx position peaked at $4.5M in Q4 2025.
108 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.

Based on Soleus Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.